Research ID
hum0240-v1Release info
Latest
Research title
Whole genome sequence analysis in patients with primary central nervous system lymphomas
Research overview
- Aims
- To explore molecular targets of primary central nervous system lymphoma (PCNSL)
- Methods
- Target amplicon sequencing analysis was performed using Target Capture technology (NGS) on Cancer Panel
- Participants/materials
- PCNSL patients
- URL
- N/A
Datasets
| Cart | Dataset ID | Type of data | Analysis method | Access criteria | Date published |
|---|---|---|---|---|---|
| JGAD000361 | NGS (Target Capture) |
| Controlled-access (Type I) | 2020-10-27 |
Data provider
- Principal investigator
- Ryuya Yamanaka
- Affiliation
- Laboratory of Molecular Targeted Therapy for Cancer, Kyoto Prefectural University of Medicine
Research projects
| Name | URL |
|---|---|
Genome-wide analysis in patients with primary central nervous system lymphomas. | N/A |
Grants
| Name | Title | Project number |
|---|---|---|
KAKENHI Grant-in-Aid for Scientific Research (B) | Exploring molecular targets for primary central nervous system lymphomas based on genome-wide analysis. |
|
KAKENHI Grant-in-Aid for Scientific Research (B) | Development of molecular targeted therapy for primary central nervous system lymphomas. |
|
Related publications
| Title | DOI | Dataset ID |
|---|---|---|
Target amplicon exome-sequencing identifies promising diagnosis and prognostic markers involved in RTK-RAS and PI3K-AKT signaling as central oncopathways in primary central nervous system lymphoma | ||
Survival prediction based on the gene expression associated with cancer morphology and microenvironment in primary central nervous system lymphoma |
Controlled access users
No use of the controlled access data has been recorded.